Cognition and Other Behavior Abnormalities in Parkinsonism and Possible Therapeutics Through Natural

来源 :2015第三届世界健康大会、首届国际失智症大会、第三届国际老年病学大会、第四届国际糖尿病学大会暨第五届国际内分泌与代谢大 | 被引量 : 0次 | 上传用户：flypig2

【摘要】

：

　　Parkinson's disease (PD) is the second most common and progressive neurodegenerative disease affecting about 1% of the aged people.The diagnosis is based on

【作者】

：

MusthafaMohamedEssa;

【机构】

：

Sultan Qaboos University Oman

【出处】

：

2015第三届世界健康大会、首届国际失智症大会、第三届国际老年病学大会、第四届国际糖尿病学大会暨第五届国际内分泌与代谢大

【发表日期】

：

2015年期

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　Parkinson's disease (PD) is the second most common and progressive neurodegenerative disease affecting about 1% of the aged people.The diagnosis is based on the presence of a set of cardinal motor signs that is a consequence of the loss of dopaminergic neurons in substantia nigra (SN) and depletion of dopamine in striatum.

其他文献

Alzheimer's Disease Biomarker of Aβ 42, Tau and Phospho-tau Study on the Australian Imaging Bio

　　The cerebrospinal fluid (CSF) Aβ 42, tau (T-tau) and phosphorylated-tau (at serine 181;P-tau) profile is established as a valuable biomarker for Alzheimer'

会议

Brain Development, Aging and Dementia Using Large Brain MRI Database

　　Now we confront a super aging society in Japan.In the situation, it is important to preserve our cognitive function for entire life by preventing us from pa

会议

Novel NMDA Modulation for Alzheimer's Disease

　　The prevalence of dementia increases rapidly worldwide.The high morbidity and mortality of dementia in the aging population add heavy burden to the society.

会议

Is AD a Medical Notion of Dementia Worth Keeping in Clinical Practice

　　AD started from 1910.Its diagnosis varies from senile dementia to senium praecox to MCI leading to AD as the most feared form of dementia.The guidelines of

会议

Hyperphosphorylated Tau as a New Target for Alzheimer's Disease Drug Discovery

　　Neurofibrillary tangles (NFTs) are a key biomarker for Alzheimer's disease (AD) and other tauopathies.NFTs are comprised primarily of hyperphosphorylated ta

会议

Comprehensive Studies on Early Diagnosis and Progression Monitor of Prodromal Alzheimer Disease: Pla

　　Comprehensive studies for identifying normal subjects and individuals with MCI due to AD or early-stage AD by medical imaging and plasma biomarker assays ar

会议

GluN2B Antagonists-Are They Good for Treating Alzheimer's Disease

　　Extensive evidence implicates GluN2Bcontaining NMDA receptors (GluN2BNMDARs) in excitotic-insult-induced neurodegeneration and amyloid β-induced synaptic d

会议

Hypnotherapy for Alzheimer's and Other Dementias

　　Improving the quality of life while living with Alzheimer's disease and other dementias,including short and long term memory,concentration and activities of

会议

Pathophysiology for Alzheimer's Disease and Dementia with Lewy Bodies Represented by CSF Biomar

　　The CSF biomarkers reflect the molecular changes in the brain.Here, I will focus on CSF soluble amyloid precursor protein β (sAPPβ)and tau in AD, and CSF

会议

Palliative Aspects of Dementia Care

　　Dementia is a terminal illness in which palliative approaches help promote well-being of patients and caregivers.Ethical dilemmas that arise at the end of l

会议

Cognition and Other Behavior Abnormalities in Parkinsonism and Possible Therapeutics Through Natural

与本文相关的学术论文